Concepedia

Timothy M. Chapman

TM

24

Publications

3K

Citations

23

H-Index

1998

Active since

Affiliations

LifeArc(Current)

University of Oxford

University of Edinburgh

Western General Hospital

The Ohio State University

Timothy M. Chapman is an author at LifeArc specializing in medicine, biochemistry, and natural sciences.

ORCID

Top concepts

Publications per year

1998–2023

24

Publications

24

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 555 citations · Full text

, , +7

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

, , +3

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 289 citations · Full text

The significance of haemochromatosis gene mutations in the general population: implications for screening

Michael J. Burt, Peter M. George, Jeff Upton et al. · Gut · 1998 · 222 citations · Full text

Rows per page

1–5 of 24